Head to Head Study of Anti-VEGF Treatment.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
An exploratory single site, open label, randomized, controlled study evaluated plasma vascular endothelial growth factor levels after intravitreal injection of ranibizumab (Lucentis) and conbercept (Langmu) for neovascular age-related macular degeneration
Epistemonikos ID: 2b0d1929247b3d425edb40159829062a96b048b7
First added on: May 12, 2024